One-Time gene injection aims to slow rare fatal brain disease in kids

This early-stage study tests a one-time gene therapy injection into the spinal fluid of children aged 1-18 with CLN7 Batten disease, a rare and fatal genetic brain disorder. The main goal is to check safety, but researchers will also measure changes in movement, thinking, and vision. Only 4 children are enrolled, so results will be very preliminary.